Skip to main content

Table 2 Results of meta-analyses with and without Non-English studies

From: Grey literature in systematic reviews: a cross-sectional study of the contribution of non-English reports, unpublished studies and dissertations to the results of meta-analyses in child-relevant reviews

Ā 

Number of studies

Number of participants

Pooled estimate (95% CI)

Summary measure

% change in effect size/CI width

Difference in estimates

Review

With non-English

Without non-English

% lost

With non-English

Without non-English

% lost

With non-English

Without non-English

Ā Ā 

Acute respiratory infections

ā€ƒVitamin C for preventing and treating the common cold (CD000980)

29

26

10.3

11306

10899

3.6

0.95 (0.92, 0.98)

RR

0.96 (0.93, 0.99)

1.1/0.0

Negligible

ā€ƒEpinephrine for bronchiolitis (CD003123)

6

5

16.7

995

965

3.0

0.67 (0.50, 0.89)

RR

0.68 (0.51, 0.91)

1.5/2.6

Negligible

ā€ƒProcalcitonin to initiate or discontinue antibiotics in ARI (CD007498)

14

13

7.1

4211

4168

1.0

0.91 (0.70, 1.19)

OR

0.90 (0.69, 1.19)

1.1/2.0

Negligible

ā€ƒImmunostimulants for preventing ARI in children (CD004974)

35

23

34.3

4060

2866

29.4

āˆ’1.24 (āˆ’1.54, -0.94)

MD

āˆ’1.27 (āˆ’1.57, āˆ’0.96)

2.4/1.7

Negligible

ā€ƒBronchodilators for bronchiolitis (CD001266)

24

23

4.2

1182

1149

2.8

āˆ’0.45 (āˆ’0.96, 0.05)

MD

āˆ’0.41 (āˆ’0.97, 0.14)

8.9/9.9

Small

ā€ƒGlucocorticoids for croup (CD001955)

14

13

7.1

1031

998

3.2

āˆ’0.59 (āˆ’0.83, -0.35)

SMD

āˆ’0.65 (āˆ’0.89, āˆ’0.41)

10.1/0.0

Small

ā€ƒAzithromycin for acute lower respiratory tract infections (CD001954)

15

14

6.7

2496

2446

2.0

1.09 (0.64, 1.85)

RR

1.03 (0.60, 1.78)

5.5/2.5

Small

ā€ƒSystemic corticosteroids for acute sinusitis (CD008115)

4

2

50.0

869

459

47.2

1.40 (1.08, 1.81)

RR

1.18 (1.05, 1.34)

15.7/60.3

Moderate

ā€ƒAntibiotics for the common cold and acute purulent rhinitis (CD000247)

6

5

16.7

1047

979

6.5

0.95 (0.59, 1.51)

RR

1.11 (0.70, 1.76)

16.8/15.2

Moderate

ā€ƒAcetylcysteine and carbocysteine for acute upper and lower RTIs in paediatric patients without chronic broncho-pulmonary disease (CD003124)

3

0

100

139

0

100

āˆ’0.05 (āˆ’0.12, 0.02)

RD

NA

NA

Substantial

ā€ƒChinese medicinal herbs for influenza (CD004559)

2

0

100

197

0

100

1.32 (0.87, 2.00)

RR

NA

NA

Substantial

Infectious diseases

ā€ƒVaccines for preventing malaria (CD006198)

3

2

33.3

307

237

22.8

1.05 (0.82, 1.35)

RR

1.05 (0.82, 1.35)

0/0

Negligible

ā€ƒProbiotics for treating acute infectious diarrhoea (CD003048)

35

34

2.9

4555

4414

3.1

āˆ’24.76 (āˆ’33.61, āˆ’15.91)

MD

āˆ’25.53 (āˆ’34.58, āˆ’16.49)

3.1/1.1

Negligible

ā€ƒHigh first dose quinine regimen for treating severe malaria (CD003341)

3

2

33.3

144

72

50.0

0.62 (0.19, 2.04)

RR

0.43 (0.09, 2.05)

30.7/5.9

Large

ā€ƒOral versus intravenous rehydration for treating dehydration due to gastroenteritis in children (CD004390)

18

15

16.7

1811

1436

20.7

0.04 (0.01, 0.07)

RD

0.02 (0.00, 0.04)

50.0/33.3

Large

(with change in statistical significance)